₹7 Cr
--
₹0 Cr
As on 13-Dec-2021 IST
₹0.10
•
5.00%
₹2.00
₹1.90
₹2.10
₹1.90
43,184
₹-- - --
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Nutraplus India
| -58.33 | -- | -- | -61.25 | -51.00 | -41.09 | -11.71 |
|
BSE Sensex*
| 9.30 | -1.94 | 8.66 | 20.87 | 12.92 | 16.01 | 11.80 |
|
BSE Healthcare#
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
|---|---|---|---|---|---|---|---|
|
Nutraplus India
| -54.14 | -45.52 | -62.19 | 71.97 | -83.80 | 456.40 | 478.15 |
|
BSE Sensex
| 15.75 | 14.38 | 5.87 | 27.91 | 1.95 | -5.03 | 29.89 |
|
BSE Healthcare
| 61.45 | -3.55 | -5.89 | 0.49 | -12.88 | 15.06 | 47.43 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Nutraplus India Ltd stood at ₹ 114 Cr as on 30-Jun-15
The share price of Nutraplus India Ltd is ₹2.10 (BSE) as of 13-Dec-2021 IST. Nutraplus India Ltd has given a return of -51% in the last 3 years.
Nutraplus India Ltd has a market capitalisation of ₹ 7 Cr as on 13-Dec-2021. As per Value Research classification, it is a company.
Since, TTM earnings of Nutraplus India Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Nutraplus India Ltd and enter the required number of quantities and click on buy to purchase the shares of Nutraplus India Ltd.
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;
The prominent promoters of Nutraplus India Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
NAIK MUKESH DHIRUBHAI |
11.4%
|
|
UDAY DESAI |
10.99%
|
|
NIDHI M NAIK |
9.68%
|
|
GITA MUKESH NAIK |
7.99%
|
The chairman of the company is Mukesh D Naik, and the managing director is Mukesh D Naik.
There is no promoter pledging in Nutraplus India Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
11,208
|
|
|
8,248
|
|
|
7,943
|
|
|
4,730
|
| Nutraplus India Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
5.12
|
|
Net Margin(%)
|
0.65
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Nutraplus India Ltd was ₹0 Cr.
₹7.16 Cr
₹--
₹-0.16 Cr
₹0.20 Cr
₹1.76 Cr
40.07%
₹-- - --
₹5.00
3,40,91,086
BSE: 524764
Mumbai, Maharashtra
www.nutraplusindia.com
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
Stocks 
Nutraplus India Ltd.
Widely used:
